Fresh analysis indicates that patients who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover lost weight much more quickly than those who halt traditional lifestyle regimens.
Research printed in a major health publication points out that while obese people often shed about a fifth of their total mass while on the medication, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing these drugs must be aware of the potential of quick rebound weight gain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to pre-treatment weight in about 18 months.
Analyzing Approaches
The study, which reviewed 37 of trials involving thousands of participants, compared the effects of the injectable medications with older methods.
Scientists point out that people who shed pounds through diet and exercise typically see a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Nutrition scientists propose the mode of action of the drugs is key to understanding the accelerated weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone concentrations several times higher than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication means appetite is no longer kept in check, making excessive eating a significant risk."
An Ongoing Disease?
Medical guidelines advise the jabs for people with weight-linked health risks, alongside recommended diet and exercise modifications.
Professionals argue that, given the high risk of weight regain, the treatment is often life-long.
This opinion is supported by drug manufacturers, who say that the findings "underscore the persistent nature of obesity," similar to managing conditions like hypertension.
User Accounts
People who have discontinued the jabs explain a sudden resurgence of cravings.
"It was like something activating and you become extremely hungry," recalled a patient.
This difficulty is worsened if users have not adopted permanent dietary or behavioural changes during treatment.
Significant Interest
Survey data suggest that millions of people in the UK have tried these injections in the past year, with desire being substantial.
- Adoption is higher among women compared to males.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion access the medications through private prescriptions rather than public health services.
Ultimately, clinicians emphasize that while these medications are powerful tools for weight loss, they are not a magic cure and lasting health benefits relies on ongoing lifestyle management.
